Business, energy, technology, markets and global industry news from Business News Today

in vitro diagnostics

PharmaDeviceNews in vitro diagnostics
Representative image: A fully automated laboratory blood-testing workflow highlights how Fujirebio’s CE-marked Lumipulse G pTau 217 Plasma assay could support scalable Alzheimer’s disease diagnostics and expand access to biomarker-based cognitive decline evaluation across Europe.
Medical Devices & Diagnostics

Why Europe’s Alzheimer’s testing pathway could shift after Fujirebio’s latest CE marking

Alzheimer’s testing needs scale, not just science. Fujirebio’s CE-marked pTau 217 assay pushes blood biomarkers closer to routine care.

Read More
Representative image: A blood-based mRNA biomarker test could mark a turning point for objective psychiatric diagnostics as Laguna Diagnostics advances its FDA breakthrough-designated tool to help clinicians differentiate schizophrenia from bipolar I disorder.
Medical Devices & Diagnostics

Why the FDA breakthrough pathway matters for Laguna Diagnostics’ psychiatric test

Psychiatry needs objective diagnostics. Laguna Diagnostics now faces the harder test: proving mRNA biomarkers can scale in real care.

Read More
Medical Devices & Diagnostics

BNB Plus completes record LineaDNA order as strategic review puts LineaRx in sharper focus

BNB Plus completed a record $1.2 million LineaDNA order for LineaRx. Read what it means for scale, margins, strategy, and BNBX stock sentiment.

Read More
Medical Devices & Diagnostics

CareDx divests Lab Products for $170m as core transplant diagnostics gains momentum

CareDx is selling its Lab Products business for $170 million. Read what the deal means for transplant diagnostics, growth focus, and execution risk.

Read More